Dare Bioscience Inc (NASDAQ:DARE)’s share price fell 0% during trading on Wednesday . The stock traded as low as $1.65 and last traded at $1.68. 3,178,600 shares were traded during trading, an increase of 644% from the average session volume of 427,341 shares. The stock had previously closed at $1.68.

Separately, ValuEngine upgraded shares of Dare Bioscience from a “strong sell” rating to a “sell” rating in a research report on Saturday, December 9th.

WARNING: This story was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://theolympiareport.com/2018/02/14/dare-bioscience-dare-trading-down-0.html.

Dare Bioscience Company Profile

Dare Bioscience, Inc, formerly Cerulean Pharma Inc, is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse.

Receive News & Ratings for Dare Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dare Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.